FACULTY 2027

Shaqil Kassam MD, Msc, FRCP

Medical Oncologist,
Magna Regional Cancer Centre,
NewMarket, ON

Dr. Shaqil Kassam is a Medical Oncologist at the Magna Regional Cancer Centre at Southlake Health in Newmarket, Ontario, where he specializes in thoracic, gastrointestinal, neuroendocrine, and skin malignancies. His clinical interests include precision oncology, molecular profiling and next-generation sequencing, biomarker-driven treatment, and immuno-oncology.

Barbara Melosky, MD, FRCP(C)

Professor of Medicine, UBC
Medical Oncologist, BC Cancer
Vancouver, BC

Dr. Melosky is a Professor of Medicine at the University of British Columbia and a Medical Oncologist in Vancouver at BC Cancer. She graduated from medical school at the University of Manitoba and did a residency in internal medicine and an oncology fellowship at the University of British Columbia. Dr. Melosky specializes in the field of thoracic malignancy. She sits on the Executive Lung Site Committee for CCTG Canadian Clinical Trials Group.

Her main focus of clinical trials is on EGFR inhibitors; she is published in this area and is considered a national and international expert. Dr. Melosky has chaired the Canadian Lung Cancer Conference for the last 12 years, which is attended by over 350 participants. She chairs and organized the multi-disciplinary Lung Cancer Journal Club three times yearly. She is chair and created the British Columbia Lung Cancer Biobank.

She is also the chairperson of the Colorectal Screening Program of British Columbia and has a special interest in EGFR receptors and management of side effects.

Brandon Sheffield MD FRCP

Medical director of immunohistochemistry and molecular pathology
Physician lead of research
William Osler Health System
Brampton, Ontario

Dr. Brandon Sheffield is an anatomic and molecular pathologist with the William Osler Health System. Dr. Sheffield specializes in the implementation and delivery of molecular diagnostics to guide cancer care. His clinical and research interests explore ways to make molecular testing more accessible to cancer patients in a publicly-funded healthcare system.

Dr. Sheffield completed medical training at the University of Toronto, Pathology residency at the University of British Columbia, he is currently serving as the physician lead of research and medical director of immunohistochemistry and molecular pathology at the William Osler Health System.

Stephanie Snow MD, FRCPC

Medical Oncologist, QEII Health Sciences Centre
Professor, Faculty of Medicine, Dalhousie University
Halifax, NS

Dr. Stephanie Snow is a staff Medical Oncologist at the QEII hospital in Halifax, Nova Scotia, treating thoracic and GI malignancies. After pursuing undergraduate training at McGill, she completed her training at Dalhousie, where she is now a full professor in the Faculty of Medicine. Dr. Snow has a strong interest in Medical Education and is Chair of the Royal College Medical Oncology Examination Board. From a research perspective she is involved in clinical research, is Associate Editor of the peer reviewed journal Current Oncology and has been widely published in prominent journals. Finally, Dr. Snow is active in patient advocacy, serving as the current Past President on Lung Cancer Canada board of directors, and sits on the medical advisory committees of several other patient advocacy groups in colorectal and gastric cancer.